Zahra Safaeinejad Selected Research

Zahra Safaeinejad Research Topics

3	Neoplasms (Cancer) 06/2022 - 01/2012
2	Weight Gain 01/2022 - 01/2021
2	Diabetes Complications 03/2021 - 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2024
1	Cardiotoxicity 06/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Insulin Resistance 11/2021
1	Hyperglycemia 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013
1	Hyponatremia 06/2013
1	Hypertension (High Blood Pressure) 06/2013
1	Brain Edema (Cerebral Edema) 06/2013
1	Stroke (Strokes) 06/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2013
1	Hydrocephalus (Hydrocephaly) 06/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2012

2	Antineoplastic Agents (Antineoplastics)IBA 06/2022 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 03/2021 - 01/2021
2	Bee Venoms (Bee Venom)IBA 10/2013 - 01/2012
1	Competitive Endogenous RNAIBA 01/2024
1	2-chloro-5-nitrobenzanilideIBA 06/2022
1	Pioglitazone (Actos)FDA Link 06/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022
1	Coffee FDA Link 01/2022
1	Chlorogenic AcidIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	MicroRNAs (MicroRNA)IBA 07/2018
1	PalladiumIBA 10/2013
1	CurcuminIBA 06/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2012

1	Therapeutics 06/2022
1	Drug Therapy (Chemotherapy) 10/2013